Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/229797
DC FieldValue
dc.titleNovel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
dc.contributor.authorLionel Rostaing
dc.contributor.authorSuphamai Bunnapradist
dc.contributor.authorJosep M. Grinyo
dc.contributor.authorKazimierz Ciechanowski
dc.contributor.authorJason E. Denny
dc.contributor.authorHelio Tedesco Silva Jr
dc.contributor.authorKlemens Budde
dc.contributor.authoron behalf of the Envarsus Study Group
dc.date.accessioned2022-08-02T06:59:32Z
dc.date.available2022-08-02T06:59:32Z
dc.date.issued2015-12-22
dc.identifier.citationLionel Rostaing, Suphamai Bunnapradist, Josep M. Grinyo, Kazimierz Ciechanowski, Jason E. Denny, Helio Tedesco Silva Jr, Klemens Budde, on behalf of the Envarsus Study Group (2015-12-22). Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. AMERICAN JOURNAL OF KIDNEY DISEASES 67 (4) : 648-659. ScholarBank@NUS Repository.
dc.identifier.issn02726386
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/229797
dc.publisherElsevier
dc.sourceElements
dc.typeArticle
dc.date.updated2022-07-24T08:01:56Z
dc.contributor.departmentMEDICINE
dc.description.sourcetitleAMERICAN JOURNAL OF KIDNEY DISEASES
dc.description.volume67
dc.description.issue4
dc.description.page648-659
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Novel Once-Daily Extended-Release Tacrolimus Versus Prograf -2016.pdf369.24 kBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.